Summary
The hemodynamic effects of the class III drugD-sotalol and of the beta adrenergic receptor antagonistD,L-sotalol were compared in 16 rats (2 mg/kg i.v.). A group with NaCl-infusion served as control (n=10). Besides measurements in the intact circulation isovolumic registrations were performed to examine the left ventricular myocardial function without interferences.D,L-sotalol significantly reduced the dp/dtmax (61%) and the peak isovolumic left ventricular pressure (64%). It lowered the heart rate by 13% and slightly increased the mean aortic pressure to 107% (p<0.05).D-sotalol, in contrast, caused only a very transient reduction of the dp/dtmax and was comparable to the controls already 5 min after injection. The results demonstrate, that theD-enantiomer is largely avoid of the hemodynamic effects of the racemicD,L-sotalol after intravenous injection.
Similar content being viewed by others
Abbreviations
- LVP:
-
systolischer linksventrikulärer Druck
- EDP:
-
enddiastolischer linksventrikulärer Druck
- AoPm:
-
mittlerer Aortendruck
- peak LVSP:
-
maximaler isovolumetrischer linksventrikulärer Druck
- peak dp/dtmax:
-
höchstes dp/dtmax bei isovolumetrischer Messung
Literatur
Fitzgerald JD, Wale JL, Austin M (1972) The haemodynamic effects of propranolol, dexpropranolol, oxprenolol, practolol and (±) sotalol in anaesthetised dogs. Europ J Pharmacol 17:123–134
Hoffmeister HM, Betz R, Fiechtner H, Seipel L (1987a) Myocardial and circulatory effects of inosine. Cardiovasc Res 21:65–71
Hoffmeister HM, Hepp A, Seipel L (1987b) Negative inotropic effect of class-I-antiarrhythmic drugs: Comparison of flecainide with disopyramide and quinidine. Europ Heart J 8:1126–1132
Hoffmeister HM, Hepp A, Seipel L (1988) Experimentelle Untersuchungen zur Hämodynamik von Disopyramid im Vergleich zu Chinidin. Z Kardiol (in Druck)
Lynch JJ, Wilber DJ, Montgomery DGM, Hsieh TM, Patterson E, Lucchesi BR (1984a) Antiarrhythmic and antifibrillatory actions of the levo-and dextrorotatory isomers of sotalol. J Cardiovasc Pharmacol 6:1132–1141
Lynch JJ, Coskey LA, Montgomery DG, Lucchesi BR, Arbor A (1985b) Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. Am Heart J 109:949
Mahmarian J, Verani MS, Hohmann T, Hill R, Thornton BC, Bolli R, Young JB, Roberts R, Pratt CM (1987) The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography. Circulation 76:324–331
Manley BS, Alexopoulus D, Robinson GJ, Cobbe SM (1986) Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol. Cardiovasc Res 20:705–709
McComb JM, McGovern B, McGowan JB, Ruskin JN, Garan H (1987) Electrophysiologic effects of d-sotalol in humans, J Am Coll Cardiol 10:211–217
Patterson E, Lynch JJ, Lucchesi BR (1984) Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, d,l-sotalol. J Pharmacol Exp Ther 230:519–526
Pfeffer MA, Pfeffer JM (1985) Left ventricular hypertrophy and pressure generating capacity in aging genetically hypertensive rats. J Cardiovasc Pharmacol 7:41–45
Singh BN, Vaughan-Williams EM (1970) A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials and other pharmacological actions on cardiac muscle of MJ 1999 and AH 3474. Br J Pharmacol 39:675
Somani P, Watson DL (1968) Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) J Pharmacol Exp Ther 164:317–325
Touboul P, Atallah G, Kirkorian G, Lamaud M, Moleur P (1984) Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties. Am Heart J 107:888–895
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der DFG
Rights and permissions
About this article
Cite this article
Hoffmeister, H.M., Seipel, L. Vergleich der hämodynamischen Wirkungen vonD-Sotalol undD,L-Sotalol. Klin Wochenschr 66, 451–454 (1988). https://doi.org/10.1007/BF01745517
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01745517